Dominique Heymann
Pr Dominique Heymann is an expert in Oncology at Institut de Cancérologie de l'Ouest (France). As of October 2026, ScienceLeadR ranks Dominique Heymann in the top 1% of experts worldwide for Sarcoma. Dominique Heymann has authored 387 publications, the most recent in 2026. SLR score: 1,412 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Biochemistry - Pharmacy - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1995 - 2026
Number : 387
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Immune profile dysregulation of high grade- compared to low grade-pseudomyxomas. PMID 42933311 — cells, genes, pseudomyxoma peritonei, pathology, immunity | Pathol Res Pract | 2026 | 0 |
| An inertial-based spiral device for separating rare tumor cells from liquid biopsies. PMID 42781301 — cells, blood, neoplastic cells, circulating, neoplasms, biopsy, liquid biopsy, osteosarcoma | Bioeng Transl Med | 2026 | 0 |
| Tetraploidy in cancer: Diagnostic and therapeutic perspectives. PMID 42269984 — cells, biochemistry, chemistry, pharmaceutical, neoplasms, therapeutics, tetraploidy | Biochem Pharmacol | 2026 | 0 |
| Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice. PMID 41813666 — factor viii, muscles, phenotype, therapeutics | Bone Res | 2026 | 0 |
| Atg5/Autophagy inactivation in mouse bone microenvironment promotes tumor development. PMID 41612597 — genes, autophagy, breast neoplasms, osteoblasts, neoplasms, neoplasm metastasis, environment, cell death, osteosarcoma | Autophagy | 2026 | 0 |
LeadR Networks
Main global connection map